ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

OXB.GB Oxford Biomedica

202.50
10.00 (5.19%)
28 Mar 2024 - Closed
Realtime Data
Share Name Share Symbol Market Type Share ISIN Share Description
Oxford Biomedica AQSE:OXB.GB Aquis Stock Exchange Ordinary Share GB00BDFBVT43
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  10.00 5.19% 202.50 195.00 210.00 202.50 192.50 192.50 0.00 16:12:47
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Oxford Biomedica PLC Holding(s) in Company (7574L)

05/10/2016 10:17am

UK Regulatory


TIDMOXB

RNS Number : 7574L

Oxford Biomedica PLC

05 October 2016

 
 
 
 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
---------------------------------------------------------------------------------------------- 
 
 1. Identity of the issuer or                                     OXFORD BIOMEDICA PLC 
  the underlying issuer 
  of existing shares to which 
  voting rights are 
  attached: (ii) 
---------------------------------------------------------------  ----------------------------- 
 2 Reason for the notification (please tick the appropriate 
  box or boxes): 
---------------------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights                                     X 
------------------------------------------------------------------  -------------------------- 
 An acquisition or disposal of qualifying financial 
  instruments which may result in the acquisition 
  of shares already issued to which voting rights 
  are attached 
------------------------------------------------------------------  -------------------------- 
 An acquisition or disposal of instruments with 
  similar economic effect to qualifying financial 
  instruments 
------------------------------------------------------------------  -------------------------- 
 An event changing the breakdown of voting rights 
------------------------------------------------------------------  -------------------------- 
 Other (please 
  specify): 
---------------------------------------------------------  -------  -------------------------- 
 3. Full name of person(s)                                    VULPES LIFE SCIENCES FUND 
  subject to the                                               VULPES TESTUDO FUND 
  notification obligation: 
  (iii) 
-----------------------------------------------------------  --------------------------------- 
 4. Full name of shareholder(s) 
  (if different from 3.):(iv) 
-----------------------------------------------------------  --------------------------------- 
 5. Date of the transaction                                   04 OCT 2016 
  and date on 
  which the threshold is 
  crossed or 
  reached: (v) 
-----------------------------------------------------------  --------------------------------- 
 6. Date on which issuer                                      05 OCT 2016 
  notified: 
-----------------------------------------------------------  --------------------------------- 
 7. Threshold(s) that is/are                                  >18% 
  crossed or 
  reached: (vi, vii) 
-----------------------------------------------------------  --------------------------------- 
 
 
 
 8. Notified details: 
-------------------------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares (viii, ix) 
-------------------------------------------------------------------------------------------------------------------------- 
 Class/type     Situation previous                  Resulting situation after the 
  of             to the triggering                   triggering transaction 
  shares         transaction 
 
  if possible 
  using 
  the ISIN 
  CODE 
-------------  ----------------------------------  ----------------------------------------------------------------------- 
                Number            Number            Number          Number of voting              % of voting 
                 of                of                of shares       rights                        rights (x) 
                 Shares            Voting 
                                   Rights 
-------------  ----------------  ----------------  --------------  ----------------------------  ------------------------- 
                                                    Direct          Direct          Indirect      Direct        Indirect 
                                                                     (xi)            (xii) 
-------------      ------------    ------------    --------------  --------------  ------------  ------------  ----------- 
 GB0006648157   475,807,928       475,807,928       575,850,000     575,850,000                   18.65% 
               ----------------  ----------------  --------------  --------------  ------------  ------------  ----------- 
 
 B: Qualifying Financial Instruments 
-------------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
-------------------------------------------------------------------------------------------------------------------------- 
 Type of            Expiration      Exercise/                         Number of voting                % of voting 
 financial           date            Conversion                        rights that                     rights 
 instrument          (xiii)          Period (xiv)                      may be 
                                                                       acquired if 
                                                                       the 
                                                                       instrument is 
                                                                       exercised/ converted. 
-----------------  --------------  --------------------------------  ------------------------------  --------------------- 
 
 
 C: Financial Instruments with similar economic effect 
  to Qualifying Financial Instruments (xv, xvi) 
-------------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
-------------------------------------------------------------------------------------------------------------------------- 
 Type of          Exercise        Expiration      Exercise/         Number of voting                % of voting 
 financial         price          date            Conversion         rights instrument               rights 
 instrument                       (xvii)          period             refers to                       (xix, xx) 
                                                  (xviii) 
---------------  --------------  --------------  ----------------  ------------------------------  ----------------------- 
                                                                                                    Nominal       Delta 
---------------  --------------  --------------  ----------------  ------------------------------  ------------  --------- 
 
 
 Total (A+B+C) 
-------------------------------------------------------------------------------------------------------------------------- 
 Number of voting rights                              Percentage of voting rights 
---------------------------------------------------  --------------------------------------------------------------------- 
 575,850,000                                          18.65% 
---------------------------------------------------  --------------------------------------------------------------------- 
 
 
 
 9. Chain of controlled undertakings through which the 
  voting rights and/or the 
  financial instruments are effectively held, if applicable: 
  (xxi) 
------------------------------------------------------------------------------------------ 
 
 
 Proxy Voting: 
------------------------------------------------------------------------------------------ 
 10. Name of the proxy holder: 
-------------------------------------------------------------  --------------------------- 
 11. Number of voting rights proxy 
  holder will cease 
  to hold: 
-------------------------------------------------------------  --------------------------- 
 12. Date on which proxy holder will 
  cease to hold 
  voting rights: 
-------------------------------------------------------------  --------------------------- 
 
 
  13. Additional information: 
-------------------------------------------------------------  --------------------------- 
 14. Contact name:                                              Tim Watts, Chief Financial 
                                                                Officer 
                                                                Oxford BioMedica 
-------------------------------------------------------------  --------------------------- 
 15. Contact telephone number:                                  +44 (0) 1865 783 000 
-------------------------------------------------------------  --------------------------- 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLUVAKRNNARRRA

(END) Dow Jones Newswires

October 05, 2016 05:17 ET (09:17 GMT)

1 Year Oxford Biomedica Chart

1 Year Oxford Biomedica Chart

1 Month Oxford Biomedica Chart

1 Month Oxford Biomedica Chart

Your Recent History

Delayed Upgrade Clock